{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:14:11Z","timestamp":1792080851986,"version":"4.4.0"},"reference-count":17,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adult-acquired Fanconi syndrome (FS) is a rare complication of monoclonal gammopathy. We retrospectively reviewed 32 patients diagnosed with adult-acquired FS between April 1968 and June 2002 at Mayo Clinic (Rochester, MN). At diagnosis, most patients had monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM), with a median creatinine level of 176.8 \u03bcM (2.0 mg\/dL; range, 79.56-327.08 \u03bcM [0.9-3.7 mg\/dL]) and evidence of osteomalacia. During the average 65 months (range, 2-238 months) of follow-up, 5 patients developed end-stage renal disease (ESRD) and only 1 of 14 patients with MGUS transformed to multiple myeloma (MM). Also, 14 deaths occurred, with only 1 from ESRD but 4 from alkylator-related leukemia or myelodysplastic syndrome. Chemotherapy offered little benefit on renal functions of MGUS or SMM patients. In conclusion, FS associated with monoclonal gammopathy does not appear to confer an additional risk of subsequent evolution to MM. ESRD occurs late in the disease process.<\/jats:p>","DOI":"10.1182\/blood-2003-10-3400","type":"journal-article","created":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T01:13:35Z","timestamp":1079399615000},"page":"40-42","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":112,"title":["Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma"],"prefix":"10.1182","volume":"104","author":[{"given":"Cynthia X.","family":"Ma","sequence":"first","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Rompala","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Greipp","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021216521958800_REF1","unstructured":"Chan KW, Ho FC, Chan MK. Adult Fanconi syndrome in kappa light chain myeloma. Arch Pathol Lab Med. 1987;111: 139-142."},{"key":"2020021216521958800_REF2","doi-asserted-by":"crossref","unstructured":"Orfila C, Lepert JC, Modesto A, Bernadet P, Suc JM. Fanconi's syndrome, kappa light-chain myeloma, non-amyloid fibrils and cytoplasmic crystals in renal tubular epithelium. Am J Nephrol. 1991;11: 345-349.","DOI":"10.1159\/000168336"},{"key":"2020021216521958800_REF3","doi-asserted-by":"crossref","unstructured":"Sewell RL, Doreen MS. Adult Fanconi syndrome progressing to multiple myeloma. J Clin Pathol. 1984;37: 1256-1258.","DOI":"10.1136\/jcp.37.11.1256"},{"key":"2020021216521958800_REF4","unstructured":"Thorner PS, Bedard YC, Fernandes BJ. Lambda-light-chain nephropathy with Fanconi's syndrome. Arch Pathol Lab Med. 1983;107: 654-657."},{"key":"2020021216521958800_REF5","unstructured":"Truong LD, Mawad J, Cagle P, Mattioli C. Cytoplasmic crystals in multiple myeloma-associated Fanconi's syndrome: a morphological study including immunoelectron microscopy. Arch Pathol Lab Med. 1989;113: 781-785."},{"key":"2020021216521958800_REF6","doi-asserted-by":"crossref","unstructured":"Uchida S, Matsuda O, Yokota T, et al. Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment for myeloma. Nephron. 1990;55: 332-335.","DOI":"10.1159\/000185986"},{"key":"2020021216521958800_REF7","doi-asserted-by":"crossref","unstructured":"Yonemura K, Matsushima H, Kato A, Isozaki T, Hishida A. Acquired Fanconi syndrome associated with IgG kappa multiple myeloma: observations on the mechanisms of impaired renal acid excretion. Nephrol Dial Transplant. 1997;12: 1251-1253.","DOI":"10.1093\/ndt\/12.6.1251"},{"key":"2020021216521958800_REF8","doi-asserted-by":"crossref","unstructured":"Maldonado JE, Velosa JA, Kyle RA, Wagoner RD, Holley KE, Salassa RM. Fanconi syndrome in adults: a manifestation of a latent form of myeloma. Am J Med. 1975;58: 354-364.","DOI":"10.1016\/0002-9343(75)90601-4"},{"key":"2020021216521958800_REF9","doi-asserted-by":"crossref","unstructured":"Isobe T, Kametani F, Shinoda T. V-domain deposition of lambda Bence Jones protein in the renal tubular epithelial cells in a patient with the adult Fanconi syndrome with myeloma. Amyloid. 1998; 5: 117-120.","DOI":"10.3109\/13506129808995289"},{"key":"2020021216521958800_REF10","doi-asserted-by":"crossref","unstructured":"Messiaen T, Deret S, Mougenot B, et al. Adult Fanconi syndrome secondary to light chain gammopathy: clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore). 2000;79: 135-154.","DOI":"10.1097\/00005792-200005000-00002"},{"key":"2020021216521958800_REF11","doi-asserted-by":"crossref","unstructured":"Aucouturier P, Bauwens M, Khamlichi AA, et al. Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. J Immunol. 1993;150: 3561-3568.","DOI":"10.4049\/jimmunol.150.8.3561"},{"key":"2020021216521958800_REF12","doi-asserted-by":"crossref","unstructured":"Rocca A, Khamlichi AA, Touchard G, et al. Sequences of V kappa L subgroup light chains in Fanconi's syndrome: light chain V region gene usage restriction and peculiarities in myeloma-associated Fanconi's syndrome. J Immunol. 1995;155: 3245-3252.","DOI":"10.4049\/jimmunol.155.6.3245"},{"key":"2020021216521958800_REF13","doi-asserted-by":"crossref","unstructured":"Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf). 1995;43: 479-490.","DOI":"10.1111\/j.1365-2265.1995.tb02621.x"},{"key":"2020021216521958800_REF14","doi-asserted-by":"crossref","unstructured":"Bate KL, Clouston D, Packham D, Ratnaike S, Ebeling PR. Lambda light chain induced nephropathy: a rare cause of the Fanconi syndrome and severe osteomalacia. Am J Kidney Dis. 1998;32: E3.","DOI":"10.1016\/S0272-6386(98)70095-2"},{"key":"2020021216521958800_REF15","unstructured":"Harrison NA, Bateman JM, Ledingham JG, Smith R. Renal failure in adult onset hypophosphatemic osteomalacia with Fanconi syndrome: a family study and review of the literature. Clin Nephrol. 1991;35: 148-150."},{"key":"2020021216521958800_REF16","doi-asserted-by":"crossref","unstructured":"Rao DS, Parfitt AM, Villanueva AR, Dorman PJ, Kleerekoper M. Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy: another form of oncogenous osteomalacia. Am J Med. 1987;82: 333-338.","DOI":"10.1016\/0002-9343(87)90081-7"},{"key":"2020021216521958800_REF17","doi-asserted-by":"crossref","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346: 564-569.","DOI":"10.1056\/NEJMoa01133202"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/1\/40\/1699857\/zh801304000040a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/1\/40\/1699857\/zh801304000040a.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T03:47:36Z","timestamp":1682653656000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/1\/40\/114431\/Acquired-Fanconi-syndrome-is-an-indolent-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-10-3400","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,1]]}}}